Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind randomized Phase II vasoconstriction and patch-test study of Polcortolon N Spray versus Volonimat Salbe N
2009-015642-35Phase 2Terminated
- Sponsor
- medphano Arzneimittel
- Start
- Dec 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of triamcinolone acetonide (2 arms), sponsored by medphano Arzneimittel. Primary endpoints: Primary efficacy endpoint and Primary tolerability endpoint. Started Dec 2009; status: terminated.
02
Drugs
triamcinolone acetonide
Beyond the preview
Go deeper on 2009-015642-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015642-35.